By making bcg available at cost in Africa to busted pension plans they would be able to reduce needless and useless and ineffective and expensive treatments for those with autoimmune diseases including lupus, multiple sclerosis, type 1 diabetes etc
See faustman lab.org pubmed.org ristori +bcg Italians only, us pro.gov Faustman inventor search
One of the key reasons behind Mr. Feinberg’s rejection was Central States’ assumption it could generate yearly investment gains of 7.5%. Those return targets “were too optimistic and unreasonable,” Mr. Feinberg said.
No comments:
Post a Comment